Charles Hugh-Jones

Chief Tech/Sci/R&D Officer at FRESENIUS MEDICAL CARE AG

56 year

Health Technology

Health Services

Profile

Charles Hugh-Jones is the Global Chief Medical Officer at Fresenius Medical Care AG, starting in 2026.
Formerly, Dr. Hugh-Jones was Chief Executive Officer at Volastra Therapeutics, Inc., Chief Medical Officer at Allergan UC from 2018 to 2020, and worked at Addleshaw Booth & Co. from 2004 to 2007.

Charles Hugh-Jones active positions

Companies	Position	Start
FRESENIUS MEDICAL CARE AG	Chief Tech/Sci/R&D Officer	01/01/2026

All active positions of Charles Hugh-Jones

Former positions of Charles Hugh-Jones

Companies	Position	End
Volastra Therapeutics, Inc. Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics	Chief Executive Officer	27/05/2025
ALLERGAN PLC	Chief Tech/Sci/R&D Officer	08/05/2020

See the detail of Charles Hugh-Jones's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles Hugh-Jones's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Fresenius Medical Care AG Fresenius Medical Care AG Medical/Nursing ServicesHealth Services Manufactures and supplies renal and dialysis products	Health Services
Allergan Ltd. (Ireland) Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products	Health Technology
Volastra Therapeutics, Inc. Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics	Health Technology